financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Adss Of Alibaba Group Holding Limited
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Adss Of Alibaba Group Holding Limited
May 14, 2024 9:12 AM

11:50 AM EDT, 05/14/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target at USD87, on a P/E of 9.6x our FY 25 (Mar.) view, below peers/historical. We reduce our FY 25 earnings per ADS view to CNY59.70 from CNY68.15 and FY 26 to CNY66.63 from CNY70.81. BABA posted Mar-Q earnings per ADS of CNY10.14 vs. CNY10.71, missing the CNY10.24 consensus. Sales rose 6.6%, slightly above expectations on international E-commerce Expansion (+45%), Logistics (+30%), and Local Services (+19%). We remain disappointed by anemic growth from Taobao/Tmall (+4%) and Cloud (+3%), 54% of sales combined. That said, BABA cited that cloud could return to double-digit growth in 2H of FY 25, excluding internal customers. We like the greater cash return to investors and the robust balance sheet (net cash of $61.8B), but expect margins to remain pressured due to more elevated investments to try to reinvigorate growth into E-commerce/Cloud. Still, we remain hesitant about prospects given pricing/competitive pressures, geopolitical uncertainty, and limited access to advanced chips.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of Johnson & Johnson To Buy From Hold
Research Alert: CFRA Raises Opinion On Shares Of Johnson & Johnson To Buy From Hold
Oct 14, 2025
11:05 AM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Q3 earnings and the announcement of the separation of Orthopedics, we raise our target to $220 from $166. This is based on 19.2x our 2026 EPS estimate and is...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Blackrock, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Blackrock, Inc.
Oct 14, 2025
12:30 AM EDT, 10/15/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $95, to $1,340, valuing BLK shares at 22x our newly initiated 2027 adjusted EPS estimate of $60.50, and at 25x our 2026 EPS...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Jpmorgan Chase & Co.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Jpmorgan Chase & Co.
Oct 14, 2025
12:20 PM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $340, applying a forward P/E of 15.5x, near the three-year historical average at 15.0x on normalized earnings. We keep our EPS estimates at...
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of The Goldman Sachs Group
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of The Goldman Sachs Group
Oct 14, 2025
02:40 PM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $850, applying a forward P/E of 15.6x our 2026 earnings estimate compared to the five-year historical average for normalized EPS at 15.5x. We...
Copyright 2023-2025 - www.financetom.com All Rights Reserved